Peripheral Artery Disease: A Comprehensive Updated Review

Curr Probl Cardiol. 2022 Nov;47(11):101082. doi: 10.1016/j.cpcardiol.2021.101082. Epub 2021 Dec 11.

Abstract

Peripheral arterial disease is estimated to affect more than 200 million people worldwide. Although more than 50% of those affected are asymptomatic, it accounts for 3%-4% of amputations and a crude 5-year death rate of 82.4 deaths per 1000 patient-years when adjusted for duration of follow-up. Additionally, peripheral artery disease is often an indicator of obstructive atherosclerotic disease involvement of cerebral and coronary vessels, consequently increasing the risk of stroke, cardiovascular death, and myocardial infarction in these patient populations. The management of peripheral arterial disease includes conservative therapies, pharmacological treatments, interventional and surgical revascularization of blood vessels. Percutaneous transluminal angioplasty with balloons and stents has improved clinical outcomes compared to medical treatment alone. Despite these advances, the prevalence of peripheral arterial disease remains high. This review article aims to provide focused, up-to-date information on the clinical course, diagnosis, medical and interventional approach of the management of peripheral artery disease.

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Coronary Vessels
  • Humans
  • Myocardial Infarction*
  • Peripheral Arterial Disease* / diagnosis
  • Peripheral Arterial Disease* / epidemiology
  • Peripheral Arterial Disease* / therapy
  • Stents
  • Treatment Outcome